Wave Life Sciences Ltd
Ownership
Ownership Structure
Who owns Wave Life Sciences Ltd (WVE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 48.0% of the shares are freely tradable; institutional investors hold 82.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 13.69 | 26,975,505 | +48.2 | 03/31/2026 |
| GSK PLC | 9.26 | 18,245,691 | +0.0 | 03/31/2026 |
| BlackRock Inc | 7.16 | 14,117,412 | +11.6 | 03/31/2026 |
| Maverick Capital Ltd | 5.16 | 10,161,399 | +9.5 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 4.42 | 8,704,550 | +17.5 | 03/31/2026 |
| Driehaus Capital Management LLC | 2.76 | 5,431,021 | -17.5 | 03/31/2026 |
| PRIMECAP Management Company | 2.72 | 5,354,622 | +10.8 | 06/30/2026 |
| FMR Inc | 2.64 | 5,192,761 | -65.7 | 03/31/2026 |
| 683 Capital Management LLC | 2.49 | 4,900,000 | +22.0 | 03/31/2026 |
| M28 Capital Management LP | 2.33 | 4,588,284 | -19.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Wagner Heidi L | Director | 44,930 | 197,692 $ | Aug 11, 2026 | direct |
| Tan Aik Na | Director | 24,968 | 109,859 $ | Aug 11, 2026 | direct |
| Takanashi Ken | Director | 20,079 | 88,348 $ | Aug 11, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Rawcliffe Adrian | Director | Sell | 12,700 | 5.29 | 67,183 |
| Aug 11, 2026 | Wagner Heidi L | Director | Sell | 7,000 | 6.01 | 42,070 |
| Aug 11, 2026 | Wagner Heidi L | Director | Other | 7,000 | 5.97 | 41,790 |
| Aug 11, 2026 | Takanashi Ken | Director | Sell | 3,864 | 6.01 | 23,223 |
| Aug 11, 2026 | Tan Aik Na | Director | Sell | 432 | 6.01 | 2,596 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.